Both SPECT/CT and PET/CT present a more diverse selection of chelating agents to try in preclinical studies
Los cambios de tallas, modelos o colores no estn permitidos, solo las devoluciones
However, the optimal wearing time would be determined by the specific product design, drug formulation, and delivery technology, and would be clearly specified in any future product's Patient Information Leaflet (PIL) if approved
Clinical trials have shown that GLP-1 receptor agonists, particularly semaglutide and liraglutide, can reduce liver fat content and improve some markers of liver inflammation
These peptides are FDA-approved for the management of type 2 diabetes, weight loss, and the reduction of cardiovascular disease